Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autografting

Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients

Abstract

This study investigated factors associated with the development of human herpesvirus (HHV)-6 encephalitis. Among 111 enrolled subjects, 12 patients developed central nervous system (CNS) dysfunction. CNS dysfunction in four patients was found to have no association with HHV-6. The remaining eight patients displayed HHV-6 encephalitis (n=3), limbic encephalitis (HHV-6 DNA in cerebrospinal fluid was not examined; n=3) or CNS dysfunction because of an unidentified cause (n=2). Real-time PCR showed CNS dysfunction in the latter eight patients, which developed concomitant with the appearance of high plasma levels of HHV-6 DNA (104 copies/ml). Overall, eight of the 24 patients with high-level HHV-6 DNA developed CNS dysfunction, whereas no patients developed CNS dysfunction potentially associated with HHV-6 infection if peak HHV-6 DNA was <104 copies/ml. We next analyzed plasma concentrations of IL-6, IL-10 and tumor necrosis factor-α among patients who displayed high-level plasma HHV-6 DNA and found elevated IL-6 concentrations preceding HHV-6 infection in patients who developed CNS dysfunction. (Mean±s.d.: 865.7±1036.3 pg/ml in patients with CNS dysfunction; 56.5±192.9 pg/ml in others; P=0.01). These results suggest that high-level HHV-6 load is necessary for the development of HHV-6 encephalitis, and systemic inflammatory conditions before HHV-6 infection form the preparatory conditions for progression to encephalopathy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Yoshikawa T, Asano Y, Ihira M, Suzuki K, Ohashi M, Suga S et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002; 185: 847–853.

    Article  PubMed  Google Scholar 

  2. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M . Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 932–940.

    Article  PubMed  Google Scholar 

  3. Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K et al. Human herpesvirus 6 DNA load in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006; 193: 68–79.

    Article  CAS  PubMed  Google Scholar 

  4. Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007; 13: 100–106.

    Article  CAS  PubMed  Google Scholar 

  5. Zerr DM . Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006; 37: 52–56.

    Article  Google Scholar 

  6. Zerr DM . Human herpesvirus 6: a clinical update. Herpes 2006; 13: 20–24.

    PubMed  Google Scholar 

  7. Ogata M, Kadota J-i . Human herpesvirus-6 infections and infection-preventative measures in transplant recipients. Future Virol 2008; 3: 567–578.

    Article  Google Scholar 

  8. Ljungman P, de la Camara R, Cordonnier C, Einsele H, Engelhard D, Reusser P et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008; 42: 227–240.

    Article  CAS  PubMed  Google Scholar 

  9. Yoshikawa T, Ihira M, Suzuki K, Suga S, Iida K, Saito Y et al. Human herpesvirus 6 infection after living related liver transplantation. J Med Virol 2000; 62: 52–59.

    Article  CAS  PubMed  Google Scholar 

  10. Ihira M, Yoshikawa T, Suzuki K, Ohashi M, Suga S, Horibe K et al. Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR. Microbiol Immunol 2002; 46: 701–705.

    Article  CAS  PubMed  Google Scholar 

  11. Tomoiu A, Flamand L . Biological and clinical advances in human herpesvirus-6 and -7 research. Future Virol 2006; 1: 623–635.

    Article  CAS  Google Scholar 

  12. Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111: 774–781.

    CAS  PubMed  Google Scholar 

  13. Ogata M, Satou T, Kawano R, Goto K, Ikewaki J, Kohno K et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008; 41: 279–285.

    Article  CAS  PubMed  Google Scholar 

  14. Fujimaki K, Mori T, Kida A, Tanaka M, Kawai N, Matsushima T et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006; 84: 432–437.

    Article  CAS  PubMed  Google Scholar 

  15. Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R . Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 705–709.

    Article  CAS  PubMed  Google Scholar 

  16. Muta T, Fukuda T, Harada M . Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study. Bone Marrow Transplant 2009; 43: 583–585.

    Article  CAS  PubMed  Google Scholar 

  17. Ito Y, Ichiyama T, Kimura H, Shibata M, Ishiwada N, Kuroki H et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol 1999; 58: 420–425.

    Article  CAS  PubMed  Google Scholar 

  18. Aiba H, Mochizuki M, Kimura M, Hojo H . Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology 2001; 57: 295–299.

    Article  CAS  PubMed  Google Scholar 

  19. Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T et al. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis 2003; 188: 690–698.

    Article  CAS  PubMed  Google Scholar 

  20. Otake Y, Yamagata T, Morimoto Y, Imi M, Mori M, Aihara T et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev 2007; 29: 117–120.

    Article  PubMed  Google Scholar 

  21. Ichiyama T, Ito Y, Kubota M, Yamazaki T, Nakamura K, Furukawa S . Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain Dev 2008 (e-pub ahead of print).

  22. Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–898.

    Article  CAS  PubMed  Google Scholar 

  23. Vogelsang GB, Hess AD . Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061–2067.

    CAS  PubMed  Google Scholar 

  24. Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV-6. Neurology 2007; 69: 156–165.

    Article  CAS  PubMed  Google Scholar 

  25. Thomas ED, Storb R, Clift RA, Fefer A, Jhonson L, Neiman PE et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895–902.

    Article  CAS  PubMed  Google Scholar 

  26. Drobyski WR, Knox KK, Majewski D, Carrigan DR . Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356–1360.

    Article  CAS  PubMed  Google Scholar 

  27. Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50: 612–619.

    Article  CAS  PubMed  Google Scholar 

  28. Fotheringham J, Akhyani N, Vortmeyer A, Donati D, Williams E, Oh U et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 2007; 195: 450–454.

    Article  CAS  PubMed  Google Scholar 

  29. Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, Fujimori Y et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419–426.

    Article  CAS  PubMed  Google Scholar 

  30. Nunoi H, Mercado MR, Mizukami T, Okajima K, Morishima T, Sakata H et al. Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int 2005; 47: 175–179.

    Article  CAS  PubMed  Google Scholar 

  31. Fujita A, Ihira M, Suzuki R, Enomoto Y, Sugiyama H, Sugata K et al. Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients. J Infect 2008; 57: 241–248.

    Article  PubMed  Google Scholar 

  32. Achour A, Boutolleau D, Gautheret-Dejean A, Agut H . Is human herpesvirus-6 DNA in plasma the right marker for active infection? J Infect Dis 2006; 194: 1795–1796.

    Article  PubMed  Google Scholar 

  33. Achour A, Boutolleau D, Slim A, Agut H, Gautheret-Dejean A . Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles. J Clin Virol 2007; 38: 280–285.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was presented in part at the Sixth International Conference on HHV-6&7 in Baltimore, MD, USA on 19–22 June 2008. The financial support was provided by Oita University Faculty of Medicine; Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research 17015047).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Ogata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogata, M., Satou, T., Kawano, R. et al. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 45, 129–136 (2010). https://doi.org/10.1038/bmt.2009.116

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.116

Keywords

This article is cited by

Search

Quick links